Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Performing a cyclic redundancy checksum operation responsive to a user-level instruction
Video editing apparatus
Rewarding independent influencers
Data center with free-space optical communications
Method and apparatus for prioritizing data transfer
Method for incubating the contents of a receptacle
Systems and methods for implementing multi-application tabs and tab sets
  Randomly Featured Patents
IC module and smart card
Systems, methods and computer program products for converting image data to nonplanar image data
Non-volatile memory with stray magnetic field compensation
Overhung radial-flow steam turbine wheel with toothed and bolted shaft connection
Information processing apparatus, method, and program for simplifying an interrupt process
Sealed battery for coordinate measurement machine
Temperature warning system for a fireplace
Electric power steering apparatus
Method and apparatus for input charge control of a power supply
Methods and systems for identifying prospective customers and managing deals